Clinical Trial Update: Effectiveness and Safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative Sterilization in Patients Undergoing Ophthalmic Surgery

View source ↗

Summary

A completed clinical trial evaluated the effectiveness and safety of perioperative 0.5% moxifloxacin ophthalmic solution in preventing postoperative endophthalm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Endophthalmitis

Drugs mentioned

• Moxifloxacin ophthalmic solution 0.5% (moxifloxacin hydrochloride)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Post Operative Endophthalmitis | Status: COMPLETED